Discovery and development of Boceprevir, an HCV NS3 protease inhibitor, for the treatment of hepatitis C infection

被引：0
|
作者：
Howe, Anita [1 ]
机构：
[1] Merck Reserach Lab, Kenilworth, NJ 07033 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2012年 / 243卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
365-BIOL
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Boceprevir, an NS3 serine protease inhibitor of hepatitis C virus, for the treatment of HCV infection
    Mederacke, Ingmar
    Wedemeyer, Heiner
    Manns, Michael P.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (02) : 181 - 189
  • [2] Boceprevir, an NS3 Protease Inhibitor of HCV
    Berman, Kenneth
    Kwo, Paul Y.
    CLINICS IN LIVER DISEASE, 2009, 13 (03) : 429 - +
  • [3] Boceprevir. NS3 protease inhibitor, Treatment of chronic hepatitis C
    Campas, C.
    Pandian, R.
    Bolos, J.
    Castaner, R.
    DRUGS OF THE FUTURE, 2009, 34 (09) : 697 - 707
  • [4] Boceprevir: A Novel NS3/4 Protease Inhibitor for the Treatment of Hepatitis C
    Klibanov, Olga M.
    Vickery, Stephen B.
    Olin, Jacqueline L.
    Smith, Lisa S.
    Williams, Shannon H.
    PHARMACOTHERAPY, 2012, 32 (02): : 173 - 190
  • [5] Boceprevir: a novel nonstructural 3 (NS3) protease inhibitor for the treatment of chronic hepatitis C infection
    Kwo, Paul Y.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2012, 5 (03) : 179 - 188
  • [6] VANIPREVIR HCV NS3/4A Protease Inhibitor Treatment of Hepatitis C
    Hammond, E.
    Lucas, A.
    Lucas, M.
    Phillips, E.
    Gaudieri, S.
    DRUGS OF THE FUTURE, 2010, 35 (10) : 803 - 813
  • [7] ASUNAPREVIR HCV Serine Protease NS3 Inhibitor Treatment of Hepatitis C Virus
    Reviriego, C.
    DRUGS OF THE FUTURE, 2012, 37 (04) : 247 - 254
  • [8] Discovery of boceprevir, a direct-acting NS3/4A protease inhibitor for treatment of chronic hepatitis C infections
    Venkatraman, Srikanth
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (05) : 289 - 294
  • [9] Furaprevir HCV NS3/4A protease inhibitor Treatment of chronic hepatitis C virus infection
    Ghosh, Prithwish
    Nehra, Vandana
    Temesgen, Zelalem
    DRUGS OF THE FUTURE, 2022, 47 (08) : 557 - 565
  • [10] The Discovery and Development of Boceprevir: A Novel, First-generation Inhibitor of the Hepatitis C Virus NS3/4A Serine Protease
    Howe, Anita Y. M.
    Venkatraman, Srikanth
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2013, 1 (01) : 22 - 32
12345